iSERA Lifesciences Ltd vs Wipro Ltd

A side-by-side comparison of iSERA Lifesciences Ltd (ISERA) and Wipro Ltd (WIPRO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Wipro Ltd leads ISERA vs WIPRO on 10 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

846.47
P/E ratio
13.91
14.67
P/B ratio
2.07
0.00%
Dividend yield
1.13%
₹0.17
EPS
₹12.58

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

-8.82%
Return on equity
15.50%
19.05%
Return on capital
18.00%
0.00%
EBITDA margin
19.00%
0.00%
Net margin
14.32%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
0.78%
Profit CAGR (3Y)
5.29%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹121 Cr
Market cap
₹1.83L Cr
₹0 Cr
Revenue
₹92,624 Cr
₹0 Cr
Net profit
₹13,266 Cr
0.20
Debt / equity
0.23
iSERA Lifesciences Ltd
  • ["Stock is trading at 14.7 times its book value", "Company has high debtors of 322 days.", "Promoter holding has decreased over last 3 years: -41.4%"]
Wipro Ltd
  • + ["Stock is providing a good dividend yield of 6.25%.", "Company has been maintaining a healthy dividend payout of 46.7%"]
  • ["The company has delivered a poor sales growth of 8.38% over past five years."]
iSERA Lifesciences Ltd full analysis Wipro Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.